58 related articles for article (PubMed ID: 2602682)
1. [A case of primary pulmonary hypertension with beneficial effect of oral long-acting prostaglandin E1 and nifedipine].
Oida A; Ogawa K; Nagao I; Tsukada K; Yoshimura M
Kokyu To Junkan; 1989 Nov; 37(11):1247-51. PubMed ID: 2602682
[TBL] [Abstract][Full Text] [Related]
2. Decrease in pulmonary artery pressure with slow release nifedipine in Saudi patients with primary pulmonary hypertension.
Ribeiro PA; Sivanandan V; Shaikh A; Chalak W; Zaman L; Duran CM
Rev Port Cardiol; 1991 May; 10(5):413-8. PubMed ID: 1910877
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates.
Radovancevic B; Vrtovec B; Thomas CD; Croitoru M; Myers TJ; Radovancevic R; Khan T; Massin EK; Frazier OH
J Heart Lung Transplant; 2005 Jun; 24(6):690-5. PubMed ID: 15949728
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical elevation of pulmonary vascular resistance after nifedipine in primary pulmonary hypertension. A case study.
Pohar B; Grad A; Mozina M; Rakovec P; Horvat M
Cor Vasa; 1989; 31(3):238-41. PubMed ID: 2766755
[TBL] [Abstract][Full Text] [Related]
5. [Hemodynamic studies of nifedipine (Adalat) in pulmonary hypertension in childhood].
Wimmer M; Schlemmer M; Ebner F
Wien Klin Wochenschr; 1986 Nov; 98(21):740-3. PubMed ID: 3101292
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in vasoconstrictor pulmonary hypertension in sheep.
Prielipp RC; Rosenthal MH; Pearl RG
Anesth Analg; 1988 Aug; 67(8):722-9. PubMed ID: 3293483
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of nifedipine in pulmonary hypertension.
Klugmann S; Salvi A; Fioretti P; Camerini F
G Ital Cardiol; 1982; 12(7):505-8. PubMed ID: 7169146
[TBL] [Abstract][Full Text] [Related]
8. Oral tadalafil in pulmonary artery hypertension: a prospective study.
Aggarwal P; Patial RK; Negi PC; Marwaha R
Indian Heart J; 2007; 59(4):329-35. PubMed ID: 19126938
[TBL] [Abstract][Full Text] [Related]
9. Differential systemic and pulmonary hemodynamic effects of L-arginine in patients with coronary artery disease or primary pulmonary hypertension.
Böger RH; Mügge A; Bode-Böger SM; Heinzel D; Höper MM; Frölich JC
Int J Clin Pharmacol Ther; 1996 Aug; 34(8):323-8. PubMed ID: 8864793
[TBL] [Abstract][Full Text] [Related]
10. Successful weaning from cardiopulmonary bypass with central venous prostaglandin E1 and left atrial norepinephrine infusion in patients with acute pulmonary hypertension.
Tritapepe L; Voci P; Cogliati AA; Pasotti E; Papalia U; Menichetti A
Crit Care Med; 1999 Oct; 27(10):2180-3. PubMed ID: 10548203
[TBL] [Abstract][Full Text] [Related]
11. [A case of pulmonary hypertensive crisis (PHC) treated with prostaglandin E1 and tolazolin after surgery of ventricular septal defect in an adult].
Inoue S; Abe T; Yamada A; Urita R; Baba M; Tsukamoto M; Komatsu S
Kyobu Geka; 1994 Nov; 47(12):1007-11. PubMed ID: 7990277
[TBL] [Abstract][Full Text] [Related]
12. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of primary pulmonary hypertension with high doses of nifedipine controlled by Doppler echocardiography].
Radomyski A; Pasierski T; Torbicki A; Tomkowski W; Filipecki S
Pneumonol Alergol Pol; 1991; 59(5-6):218-23. PubMed ID: 1843925
[TBL] [Abstract][Full Text] [Related]
14. Long-term favourable effect of nifedipine in primary pulmonary hypertension. Report of a case with hemodynamic evaluation after 3 and after 16 months and with clinical follow-up during 36 months.
Musante R; Di Donato M
G Ital Cardiol; 1985 Nov; 15(11):1110-2. PubMed ID: 3830769
[TBL] [Abstract][Full Text] [Related]
15. [Nifedipine in the treatment of chronic cor pulmonale].
Saadjian A; Philip-Joet F; Tran N'guyen A; Arnaud A; Torresani J
Arch Mal Coeur Vaiss; 1986 Jan; 79(1):76-83. PubMed ID: 3085613
[TBL] [Abstract][Full Text] [Related]
16. Transient effect of nifedipine on pulmonary hypertension of systemic sclerosis.
Fudman EJ; Kelling DG
J Rheumatol; 1985 Dec; 12(6):1191-2. PubMed ID: 4093929
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
[TBL] [Abstract][Full Text] [Related]
18. [Sildenafil reduces pressure and pulmonary resistance and increases susceptibility of pulmonary arteries to nitric oxide in primary pulmonary arterial hypertension].
Wodniecki J; Jacheć W; Poloński L; Tomasik AR; Wojciechowska C; Foremny A
Przegl Lek; 2005; 62(2):135-8. PubMed ID: 16095162
[TBL] [Abstract][Full Text] [Related]
19. Acute and long term effect of nifedipine on pulmonary hypertension secondary to chronic obstructive airways disease.
Johnson DC; Joshi RC; Mehta R; Cunnington AR
Eur J Respir Dis Suppl; 1986; 146():495-502. PubMed ID: 3465575
[TBL] [Abstract][Full Text] [Related]
20. Two-week nifedipine treatment for pulmonary hypertension complicating chronic obstructive lung disease.
Saadjian A; Philip-Joet F; Guintoli A; Torresani J; Arnaud A
Eur J Respir Dis; 1985 Nov; 67(5):346-50. PubMed ID: 4085586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
